1. Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2008). Estimates of worldwide burden of cancer in 2008: GLOBOCAN. International Journal of Cancer, 127(2010), 2893–2917.
2. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61, 69–90.
3. Andreana, L., Isgro, G., Marelli, L., Davies, N., Yu, D., Navalkissoor, S., et al. (2012). Treatment of hepatocellular carcinoma (HCC) by intra-arterial infusion of radio-emitter compounds: Trans-arterial radio-embolisation of HCC. Cancer Treatment Reviews, 38, 641–649.
4. Thomas, M. B., O’Beirne, J. P., Furuse, J., Chan, A. T., Abou-Alfa, G., & Johnson, P. (2008). Systemic therapy for hepatocellular carcinoma: Cytotoxic chemotherapy, targeted therapy and immunotherapy. Annals of Surgical Oncology, 15, 1008–1014.
5. Way, T. D., Lee, J. C., Kuo, D. H., Fan, L. L., Huang, C. H., Lin, H. Y., et al. (2010). Inhibition of epidermal growth factor receptor signaling by Saussurea involucrata, a rare traditional Chinese medicinal herb, in human hormone-resistant prostate cancer PC-3 cells. Journal of Agriculture and Food Chemistry, 58, 3356–3365.